Skip to main content
Top
Gepubliceerd in:

02-11-2017

Evidence-based maatwerk voor ouderen met kanker

Auteurs: Marije E. Hamaker, Frederiek van den Bos

Gepubliceerd in: Tijdschrift voor Gerontologie en Geriatrie | Uitgave 6/2017

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Kanker treft vooral oudere mensen. Evidence-based behandeling is de gouden standaard van de huidige medische zorg, ook bij ouderen met kanker. Bij het opstellen van richtlijnen wordt al het beschikbare wetenschappelijk bewijs verzameld, gewogen en samengevat. De daaruit voortvloeiende adviezen worden vervolgens vertaald naar kwaliteitscriteria waarmee de kwaliteit van zorg wordt gemeten. Tegenover de vaak rigide behandeladviezen zoals deze in richtlijnen en protocollen worden geformuleerd, staat de heterogeniteit van de oudere populatie. Dit vraagt om zorg op maat. Dit artikel bespreekt een aantal aandachtspunten rond dit spanningsveld tussen evidence-based behandelen en zorg op maat bij ouderen met kanker.
Literatuur
1.
go back to reference Integraal Kankercentrum Nederland. Kankerzorg in beeld: de oudere patient. 2016. Integraal Kankercentrum Nederland. Kankerzorg in beeld: de oudere patient. 2016.
4.
go back to reference Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. 2011. Version 5.1.0. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. 2011. Version 5.1.0.
5.
go back to reference Mol L, Koopman M, Gils CW van, Ottevanger PB, Punt CJ. Comparison of treatment outcome in metastatic colorectal cancer patients included in a clinical trial versus daily practice in The Netherlands. Acta Oncol. 2013;52:950–5.CrossRefPubMed Mol L, Koopman M, Gils CW van, Ottevanger PB, Punt CJ. Comparison of treatment outcome in metastatic colorectal cancer patients included in a clinical trial versus daily practice in The Netherlands. Acta Oncol. 2013;52:950–5.CrossRefPubMed
6.
go back to reference Charlson ME, Horwitz RI. Applying results of randomised trials to clinical practice: impact of losses before randomisation. Br Med J (Clin Res Ed). 1984;289:1281–4.CrossRef Charlson ME, Horwitz RI. Applying results of randomised trials to clinical practice: impact of losses before randomisation. Br Med J (Clin Res Ed). 1984;289:1281–4.CrossRef
7.
go back to reference Rothwell PM. External validity of randomised controlled trials: “to whom do the results of this trial apply?”. Lancet. 2005;365:82–93.CrossRefPubMed Rothwell PM. External validity of randomised controlled trials: “to whom do the results of this trial apply?”. Lancet. 2005;365:82–93.CrossRefPubMed
8.
go back to reference Zulman DM, Sussman JB, Chen X, Cigolle CT, Blaum CS, Hayward RA. Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med. 2011;26:783–90.CrossRefPubMedPubMedCentral Zulman DM, Sussman JB, Chen X, Cigolle CT, Blaum CS, Hayward RA. Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med. 2011;26:783–90.CrossRefPubMedPubMedCentral
9.
go back to reference Beers E, Moerkerken DC, Leufkens HG, Egberts TC, Jansen PA. Participation of older people in preauthorization trials of recently approved medicines. J Am Geriatr Soc. 2014;62:1883–90.CrossRefPubMed Beers E, Moerkerken DC, Leufkens HG, Egberts TC, Jansen PA. Participation of older people in preauthorization trials of recently approved medicines. J Am Geriatr Soc. 2014;62:1883–90.CrossRefPubMed
10.
go back to reference Lewis JH, Kilgore ML, Goldman DP, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol. 2003;21:1383–9.CrossRefPubMed Lewis JH, Kilgore ML, Goldman DP, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol. 2003;21:1383–9.CrossRefPubMed
12.
go back to reference Ferrucci L, Guralnik JM, Cavazzini C, et al. The frailty syndrome: a critical issue in geriatric oncology. Crit Rev Oncol Hematol. 2003;46:127–37.CrossRefPubMed Ferrucci L, Guralnik JM, Cavazzini C, et al. The frailty syndrome: a critical issue in geriatric oncology. Crit Rev Oncol Hematol. 2003;46:127–37.CrossRefPubMed
13.
go back to reference Jolly TA, Deal AM, Nyrop KA, et al. Geriatric assessment-identified deficits in older cancer patients with normal performance status. Oncologist. 2015;20:379–85.CrossRefPubMedPubMedCentral Jolly TA, Deal AM, Nyrop KA, et al. Geriatric assessment-identified deficits in older cancer patients with normal performance status. Oncologist. 2015;20:379–85.CrossRefPubMedPubMedCentral
14.
go back to reference Wildiers H, Heeren P, Puts M, et al. International society of geriatric oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol. 2014;32:2595–603.CrossRefPubMedPubMedCentral Wildiers H, Heeren P, Puts M, et al. International society of geriatric oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol. 2014;32:2595–603.CrossRefPubMedPubMedCentral
15.
go back to reference Hamaker ME, Vos AG, Smorenburg CH, Rooij SE de, Munster BC van. The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer. Oncologist. 2012;17:1439–49.CrossRefPubMedPubMedCentral Hamaker ME, Vos AG, Smorenburg CH, Rooij SE de, Munster BC van. The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer. Oncologist. 2012;17:1439–49.CrossRefPubMedPubMedCentral
16.
go back to reference Hamaker ME, Schiphorst AH, Bokkel HD ten, Schaar C, Munster BC van. The effect of a geriatric evaluation on treatment decisions for older cancer patients – a systematic review. Acta Oncol. 2014;53:289–96.CrossRefPubMed Hamaker ME, Schiphorst AH, Bokkel HD ten, Schaar C, Munster BC van. The effect of a geriatric evaluation on treatment decisions for older cancer patients – a systematic review. Acta Oncol. 2014;53:289–96.CrossRefPubMed
17.
go back to reference Balducci L, Extermann M. Management of cancer in the older person: a practical approach. Oncologist. 2000;5:224–37.CrossRefPubMed Balducci L, Extermann M. Management of cancer in the older person: a practical approach. Oncologist. 2000;5:224–37.CrossRefPubMed
18.
go back to reference Corre R, Greillier L, Le CH, et al. Use of a comprehensive geriatric assessment for the management of elderly patients with advanced non-small-cell lung cancer: the phase III randomized ESOGIA-GFPC-GECP 08-02 study. J Clin Oncol. 2016;34:1476–83.CrossRefPubMed Corre R, Greillier L, Le CH, et al. Use of a comprehensive geriatric assessment for the management of elderly patients with advanced non-small-cell lung cancer: the phase III randomized ESOGIA-GFPC-GECP 08-02 study. J Clin Oncol. 2016;34:1476–83.CrossRefPubMed
20.
go back to reference Schiphorst AH, Jonker JM, Struikmans H, Rozema T, Pronk A, Portielje JE, et al. Geriatrisch oncologie in Nederland: een enquete naar de huidige zorg, knelpunten en mogelijkheden tot verbetering. Tijdschr Oncol. 2014;11:293–300. Schiphorst AH, Jonker JM, Struikmans H, Rozema T, Pronk A, Portielje JE, et al. Geriatrisch oncologie in Nederland: een enquete naar de huidige zorg, knelpunten en mogelijkheden tot verbetering. Tijdschr Oncol. 2014;11:293–300.
21.
go back to reference Taylor C, Munro AJ, Glynne-Jones R, et al. Multidisciplinary team working in cancer: what is the evidence? BMJ. 2010;340:c951.CrossRefPubMed Taylor C, Munro AJ, Glynne-Jones R, et al. Multidisciplinary team working in cancer: what is the evidence? BMJ. 2010;340:c951.CrossRefPubMed
22.
go back to reference Saini KS, Taylor C, Ramirez AJ, et al. Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries. Ann Oncol. 2012;23:853–9.CrossRefPubMed Saini KS, Taylor C, Ramirez AJ, et al. Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries. Ann Oncol. 2012;23:853–9.CrossRefPubMed
23.
go back to reference Lamb BW, Sevdalis N, Benn J, Vincent C, Green JS. Multidisciplinary cancer team meeting structure and treatment decisions: a prospective correlational study. Ann Surg Oncol. 2013;20:715–22.CrossRefPubMed Lamb BW, Sevdalis N, Benn J, Vincent C, Green JS. Multidisciplinary cancer team meeting structure and treatment decisions: a prospective correlational study. Ann Surg Oncol. 2013;20:715–22.CrossRefPubMed
24.
go back to reference Lamb BW, Sevdalis N, Arora S, Pinto A, Vincent C, Green JS. Teamwork and team decision-making at multidisciplinary cancer conferences: barriers, facilitators, and opportunities for improvement. World J Surg. 2011;35:1970–6.CrossRefPubMed Lamb BW, Sevdalis N, Arora S, Pinto A, Vincent C, Green JS. Teamwork and team decision-making at multidisciplinary cancer conferences: barriers, facilitators, and opportunities for improvement. World J Surg. 2011;35:1970–6.CrossRefPubMed
25.
go back to reference Lamb BW, Taylor C, Lamb JN, et al. Facilitators and barriers to teamworking and patient centeredness in multidisciplinary cancer teams: findings of a national study. Ann Surg Oncol. 2013;20:1408–16.CrossRefPubMed Lamb BW, Taylor C, Lamb JN, et al. Facilitators and barriers to teamworking and patient centeredness in multidisciplinary cancer teams: findings of a national study. Ann Surg Oncol. 2013;20:1408–16.CrossRefPubMed
26.
go back to reference Basch E, Jia X, Heller G, et al. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst. 2009;101:1624–32.CrossRefPubMedPubMedCentral Basch E, Jia X, Heller G, et al. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst. 2009;101:1624–32.CrossRefPubMedPubMedCentral
27.
go back to reference Corner J, Wright D, Hopkinson J, Gunaratnam Y, McDonald JW, Foster C. The research priorities of patients attending UK cancer treatment centres: findings from a modified nominal group study. Br J Cancer. 2007;96:875–81.CrossRefPubMedPubMedCentral Corner J, Wright D, Hopkinson J, Gunaratnam Y, McDonald JW, Foster C. The research priorities of patients attending UK cancer treatment centres: findings from a modified nominal group study. Br J Cancer. 2007;96:875–81.CrossRefPubMedPubMedCentral
28.
go back to reference Extermann M, Albrand G, Chen H, et al. Are older French patients as willing as older American patients to undertake chemotherapy? J Clin Oncol. 2003;21:3214–9.CrossRefPubMed Extermann M, Albrand G, Chen H, et al. Are older French patients as willing as older American patients to undertake chemotherapy? J Clin Oncol. 2003;21:3214–9.CrossRefPubMed
29.
go back to reference Yellen SB, Cella DF, Leslie WT. Age and clinical decision making in oncology patients. J Natl Cancer Inst. 1994;86:1766–70.CrossRefPubMed Yellen SB, Cella DF, Leslie WT. Age and clinical decision making in oncology patients. J Natl Cancer Inst. 1994;86:1766–70.CrossRefPubMed
30.
go back to reference Hamaker ME, Stauder R, Munster BC van. On-going clinical trials for elderly patients with a hematological malignancy: are we addressing the right end points? Ann Oncol. 2014;25:675–81.CrossRefPubMedPubMedCentral Hamaker ME, Stauder R, Munster BC van. On-going clinical trials for elderly patients with a hematological malignancy: are we addressing the right end points? Ann Oncol. 2014;25:675–81.CrossRefPubMedPubMedCentral
31.
go back to reference Hamaker ME, Schulkes KJ, Bokkel HD ten, Munster BC van, Huis LH van, Bos F van den. Evaluation and reporting of quality of life outcomes in phase III chemotherapy trials for poor prognosis malignancies. Qual Life Res. 2017;26:65–71.CrossRefPubMed Hamaker ME, Schulkes KJ, Bokkel HD ten, Munster BC van, Huis LH van, Bos F van den. Evaluation and reporting of quality of life outcomes in phase III chemotherapy trials for poor prognosis malignancies. Qual Life Res. 2017;26:65–71.CrossRefPubMed
32.
go back to reference Visser J. De arts staat in de behandelmodus. Med Contact (Bussum). 2012;67:1329. Visser J. De arts staat in de behandelmodus. Med Contact (Bussum). 2012;67:1329.
33.
go back to reference Christakis NA, Lamont EB. Extent and determinants of error in physicians’ prognoses in terminally ill patients: prospective cohort study. West J Med. 2000;172:310–3.CrossRefPubMedPubMedCentral Christakis NA, Lamont EB. Extent and determinants of error in physicians’ prognoses in terminally ill patients: prospective cohort study. West J Med. 2000;172:310–3.CrossRefPubMedPubMedCentral
34.
go back to reference Berg JW van den, Venema G, Uil S, Kloosterziel C. Chemo wordt te lang doorgezet. Med Contact (Bussum). 2013;39:1974–5. Berg JW van den, Venema G, Uil S, Kloosterziel C. Chemo wordt te lang doorgezet. Med Contact (Bussum). 2013;39:1974–5.
35.
go back to reference Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363:733–42.CrossRefPubMed Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363:733–42.CrossRefPubMed
Metagegevens
Titel
Evidence-based maatwerk voor ouderen met kanker
Auteurs
Marije E. Hamaker
Frederiek van den Bos
Publicatiedatum
02-11-2017
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Tijdschrift voor Gerontologie en Geriatrie / Uitgave 6/2017
Print ISSN: 0167-9228
Elektronisch ISSN: 1875-6832
DOI
https://doi.org/10.1007/s12439-017-0235-3

Andere artikelen Uitgave 6/2017

Tijdschrift voor Gerontologie en Geriatrie 6/2017 Naar de uitgave